ECSP077416A - Mimeticuerpos que se unen al receptor de melanocortina, composiciones, metodos y usos - Google Patents

Mimeticuerpos que se unen al receptor de melanocortina, composiciones, metodos y usos

Info

Publication number
ECSP077416A
ECSP077416A EC2007007416A ECSP077416A ECSP077416A EC SP077416 A ECSP077416 A EC SP077416A EC 2007007416 A EC2007007416 A EC 2007007416A EC SP077416 A ECSP077416 A EC SP077416A EC SP077416 A ECSP077416 A EC SP077416A
Authority
EC
Ecuador
Prior art keywords
methods
mimeticbodies
join
compositions
melanocortine
Prior art date
Application number
EC2007007416A
Other languages
English (en)
Spanish (es)
Inventor
Chichi Huang
Mark Cunningham
Vedrana Stojanovic-Susulic
Karyn O'neil
Jeffrey Luo
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of ECSP077416A publication Critical patent/ECSP077416A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EC2007007416A 2004-10-25 2007-04-25 Mimeticuerpos que se unen al receptor de melanocortina, composiciones, metodos y usos ECSP077416A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62196004P 2004-10-25 2004-10-25

Publications (1)

Publication Number Publication Date
ECSP077416A true ECSP077416A (es) 2007-05-30

Family

ID=36228385

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007416A ECSP077416A (es) 2004-10-25 2007-04-25 Mimeticuerpos que se unen al receptor de melanocortina, composiciones, metodos y usos

Country Status (28)

Country Link
US (1) US20060105951A1 (https=)
EP (1) EP1812046B1 (https=)
JP (1) JP2008517605A (https=)
KR (1) KR101255140B1 (https=)
CN (1) CN101437540B (https=)
AT (1) ATE501731T1 (https=)
AU (1) AU2005299440B2 (https=)
BR (1) BRPI0518411A2 (https=)
CA (1) CA2585287A1 (https=)
CY (1) CY1111486T1 (https=)
DE (1) DE602005026970D1 (https=)
DK (1) DK1812046T3 (https=)
EA (1) EA200700944A1 (https=)
EC (1) ECSP077416A (https=)
ES (1) ES2363023T3 (https=)
HR (1) HRP20110405T1 (https=)
IL (1) IL182683A0 (https=)
MA (1) MA28943B1 (https=)
ME (1) ME01234B (https=)
MX (1) MX2007004974A (https=)
NO (1) NO20072499L (https=)
PL (1) PL1812046T3 (https=)
PT (1) PT1812046E (https=)
RS (1) RS51789B (https=)
SI (1) SI1812046T1 (https=)
TN (1) TNSN07157A1 (https=)
WO (1) WO2006047535A2 (https=)
ZA (1) ZA200704260B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910101B2 (en) * 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
TW201002340A (en) * 2008-06-09 2010-01-16 Palatin Technologies Inc Melanocortin receptor-specific peptides for treatment of obesity
KR101687037B1 (ko) * 2008-06-09 2016-12-15 팔라틴 테크놀로지스 인코포레이티드 성기능 장애 치료용 멜라노코르틴 수용체-특이적 펩티드
US8614185B2 (en) * 2009-05-04 2013-12-24 Centocor Ortho Biotech Inc. Fusion proteins of alpha-MSH derivatives and Fc
KR101726893B1 (ko) 2009-06-08 2017-04-13 팔라틴 테크놀로지스 인코포레이티드 멜라노코르틴 수용체-특이적 펩티드
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
WO2010144341A2 (en) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
WO2011063366A1 (en) 2009-11-23 2011-05-26 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
JP2013511554A (ja) 2009-11-23 2013-04-04 パラティン テクノロジーズ，インコーポレイテッド メラノコルチン−１受容体特異的線状ペプチド
JP2020141710A (ja) * 2011-07-06 2020-09-10 ゲンマブ エー／エス 抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
CN113272330B (zh) * 2019-03-02 2024-07-26 南通壹宸生物医药科技有限公司 一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033658A1 (en) * 1998-12-09 2000-06-15 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
WO2002006316A2 (en) * 2000-07-14 2002-01-24 Zycos, Inc. Alpha-msh related compounds and methods of use
AU2003280130B2 (en) * 2002-06-28 2009-06-11 Centocor, Inc. Mammalian CH1 deleted mimetibodies, compositions, methods and uses
JP2005536992A (ja) * 2002-06-28 2005-12-08 セントカー・インコーポレーテツド 哺乳動物のｅｐｏ模倣ｃｈ１欠失ミメティボディ、組成物、方法および使用
JP2008537873A (ja) * 2004-03-31 2008-10-02 セントカー・インコーポレーテツド ヒトｇｌｐ−１ミメティボディ、組成物、方法および用途

Also Published As

Publication number Publication date
ZA200704260B (en) 2009-03-25
US20060105951A1 (en) 2006-05-18
DK1812046T3 (da) 2011-06-06
JP2008517605A (ja) 2008-05-29
AU2005299440B2 (en) 2011-12-15
HRP20110405T1 (hr) 2011-06-30
EP1812046B1 (en) 2011-03-16
BRPI0518411A2 (pt) 2008-11-18
CN101437540A (zh) 2009-05-20
ES2363023T3 (es) 2011-07-19
MA28943B1 (fr) 2007-10-01
SI1812046T1 (sl) 2011-06-30
DE602005026970D1 (de) 2011-04-28
TNSN07157A1 (en) 2008-11-21
AU2005299440A1 (en) 2006-05-04
PL1812046T3 (pl) 2011-08-31
RS51789B (sr) 2011-12-31
WO2006047535A3 (en) 2008-09-04
HK1106445A1 (en) 2008-03-14
NO20072499L (no) 2007-07-16
CA2585287A1 (en) 2006-05-04
EP1812046A4 (en) 2009-11-11
KR20070085416A (ko) 2007-08-27
ME01234B (me) 2013-06-20
PT1812046E (pt) 2011-06-28
ATE501731T1 (de) 2011-04-15
MX2007004974A (es) 2007-10-17
WO2006047535A2 (en) 2006-05-04
IL182683A0 (en) 2007-09-20
CN101437540B (zh) 2012-12-19
CY1111486T1 (el) 2015-08-05
EA200700944A1 (ru) 2008-04-28
KR101255140B1 (ko) 2013-04-22
EP1812046A2 (en) 2007-08-01

Similar Documents

Publication Publication Date Title
ECSP077416A (es) Mimeticuerpos que se unen al receptor de melanocortina, composiciones, metodos y usos
WO2007041635A3 (en) Fc variants with optimized fc receptor binding properties
CR20140518A (es) Antagonistas neuropilina
PT1971366E (pt) Anticorpos humanos anti-il-23, composições, métodos e usos
MX2010007716A (es) Combinacion de una proteina de fusion del anticuerpo-il-2 de anti-edb fibronectina y una molecula que se une a celulas b, progenitores de la celula b y/o sus contrapartes cancerigenas.
TW200720076A (en) Composite materials and methods of making the same
NO345048B1 (no) Antigen-bindende protein som binder til humant IGF-1R, polynukleotid som koder for dette, samt plasmid og celle, og farmasøytisk sammensetning.
BRPI0613770A2 (pt) anticorpos anti-cd26 e métodos de uso destes
WO2006083276A3 (en) Interferon-alpha polypeptides and conjugates
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
WO2009007852A3 (en) Multipotent/pluripotent cells and methods
EP1991560A4 (en) PEPTIDE WITH CELL MEMBRANE PENETRATING EFFECT
DK1951273T3 (da) Anvendelse af lactobacillus til behandling af autoimmune sygdomme
BRPI0519000A2 (pt) variantes de il-7 com imunogenicidade reduzida
DK1864132T3 (da) Fra amnion stammende cellesammensætninger, fremgangsmåder til fremstilling deraf og anvendelser deraf
EP2115461A4 (en) NEW SPECIFIC CELL BINDERS
GT200900035A (es) Anticuerpo especifico prlr y sus usos
MA32190B1 (fr) Anticorps dirigés contre l'angiopoïétine 1 et l'angiopoïétine 2 et leur utilisation
WO2005113592A3 (en) Interferon-alpha polypeptides and conjugates
CR9637A (es) Proteinas de enlace il-6
DK1919514T3 (da) Polynucleotider kodende for isoprenoid-modificerende enzymer og fremgangsmåder til anvendelse deraf
WO2008017074A3 (en) Dyes and precursors and conjugates thereof
WO2008086035A3 (en) Split mutant hydrolase fusion reporter and uses thereof
WO2007044083A3 (en) Evolved interferon-alpha polypeptides
BRPI0719708A2 (pt) Novos moduladores de proteína quinase e seus usos terapêuticos.